How Cognizant Is Powering Health Care's Data Revolution
Health care is undergoing a fundamental transformation from a labor-intensive industry to a data-intensive sector, as artificial intelligence revolutionizes how health care organizations handle everything from insurance claims to drug discovery, representing the biggest operational shift since the introduction of electronic medical records.
Take one of health care's most onerous administrative tasks: provider credentialing, the laborious process of enrolling doctors in insurance networks with varying coding across multiple insurance plans and geographic regions, which can consume weeks or months of work from dozens of staff members.
"Now, with AI, we can get the task done within hours, if not minutes," explains Surya Gummadi, president of Cognizant Americas. AI is creating these kinds of efficiencies in back-office functions, faster clinical trials for pharmaceutical companies bringing treatments to market and real-time insurance authorization that helps health care providers streamline patient care decisions.
Photo-illustration by Newsweek/Canva
Cognizant, whose platforms are used by two-thirds of the U.S. insured population, approaches health care AI through what Gummadi calls three distinct vectors. Companies first enhance productivity through AI tools and models. They then focus on helping clients "infuse AI across their technology stack"—preparing data layers and applications for AI integration. And the final step, he says, is "agentification," which can coordinate multiple AI processes to handle complex tasks.
"We have agentified our intranet," Gummadi explains. For example, if a Cognizant employee has a major life event, such as a new baby, they do not need to update their information in multiple systems for health insurance and paid time off. "Just one single update," he says, "and the agents across the intranet will coordinate and make it seamless for the associate."
Anchoring Cognizant's role in the administrative backbone that keeps the American health insurance sector functioning is its $2.7 billion acquisition of TriZetto in 2014, which created one of the largest health care technology infrastructures in the United States. TriZetto's platforms serve approximately 350 health insurers, covering about 180 million lives, processing everything from claims adjudication to benefits enrollment.
"We are not approaching AI as a technology solution," Gummadi says. "We are approaching AI as an enterprise solution to help our clients in their business outcomes." This focus on outcomes rather than technology has allowed Cognizant to address what he describes as "value pools that we never had access to," including core business functions that were previously kept in-house.
This shift toward data-driven operations represents more than a technological upgrade—it's health care evolving into an industry where intelligent information processing, rather than human labor alone, drives core functions and patient outcomes. "Twelve months ago, most of the enterprises were a bit skeptical, and they were approaching AI more from an experimentation angle," Gummadi notes. "Now, many companies in different sectors are moving from experimentation to scale."
While regulatory concerns initially slowed AI adoption in health care's highly regulated environment, there are now ways for organizations to "leverage AI by staying within the regulatory guardrails." And as health care organizations race to implement AI solutions, they increasingly opt for outside services rather than build proprietary systems. "There is a common agreement across clients and the service providers that there is no point in reinventing the wheel. So, there is more appetite for partnerships," Gummadi says. "All of us are racing against time when it comes to AI."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
32 minutes ago
- Business Insider
The CEO building the 'Ikea of factories' wants to democratize semiconductor production
In his 1986 book "Engines of Creation," engineer K. Eric Drexler — often called the godfather of nanotechnology — made a prediction. "The coming era of molecular machines will mean the end of many limits: the limit of scarcity, the limit of slow development, the limit of ignorance enforced by the lack of tools," he wrote. Reading those words a few years later, when he was 16, Matthew Putman started thinking. "Our bodies work as these little micro-machines where you have ribosomes and enzymes and things that are working and replicating and making things all the time, but our factories work the way that they've worked for the last hundred years," Putman told Business Insider he thought at the time. He wondered how a world would look "where you don't have large assembly lines, you don't have smokestacks, you instead just make things so perfectly," he said. Putman became fascinated by the possibilities of machines that are "atomically precise." It wasn't until the recent AI boom, however, that the idea really took off with fabrication plants. Putman, now 50, is the CEO of Brooklyn-based Nanotronics, which he cofounded with his father in 2010. The company started out building microscopes and tools to detect defects in semiconductors, among other materials. Now, it builds small, modular semiconductor manufacturing plants called Cubefabs. While the biggest fabs in the country are often millions of square feet in size, Cubefabs measure anywhere from 25,000 square feet for the smallest units up to about 60,000 square feet for a full-sized fab. They're adaptable, and the company says they can be assembled in under a year in most places on Earth. They're also smart — thanks to the power of AI — so they can self-monitor their production and improve in real time, the company said. And they're relatively cheap, costing a minimum of $30 to $40 million, compared to large fabs that can cost billions to build. With President Donald Trump back in the White House and pledging to reinvigorate US manufacturing, a new opening has emerged for Nanotronics — even as sweeping tariffs challenge companies that produce or depend on semiconductors. Putman says that in the long term, the tariffs will bolster domestic innovation. Tariffs "should be a wake-up call — a push to create something better than what either the US or China has done before," he told BI in a video interview from the Nanotronics headquarters in Brooklyn Navy Yard. "If we get this right, American innovation won't just protect our future — it could help redefine global progress in a way that benefits humanity." Putman says compact, modular factories are exactly that. "Your factory should be incredibly small," Putman said, gesturing to the room behind him. "Eventually, it could be the size of this room." The 'Ikea of factories' Semiconductor manufacturing has surged since the launch of ChatGPT. Global annual revenue for the industry is expected to reach more than $1 trillion by 2030, according to McKinsey & Company. In the US, despite legislation subsidizing domestic semiconductor production, fabs are more expensive to construct and maintain than those built in places like mainland China and Taiwan, McKinsey says. The US also suffers from a shortage of qualified labor, which can delay construction timelines, according to the firm. To attempt to solve some of these issues, Nanotronics teamed up with architecture firm Rogers Partners and engineering firm Arup to design compact factories. Each one runs with 37 people, but Putman says the ideal setup is four factories — about 180 workers total — which allows them to scale up without halting production. "It's like the Ikea of factories," Putman said. The company has raised $182 million to date from firms including Peter Thiel's Founders Fund. Cubefabs can be used to produce chips that span a range of uses across electronics applications, electric vehicles, and photodetectors for cube satellites, Putman said. "The more precise we make things, the more abundance we bring to the world," he said. "The business of making things grow bigger and bigger starts small — molecular small." Building on the foundational research of scientist Philippe Bove — now chief scientist at Nanotronics — the company also uses gallium oxide — a type of semiconductor that can handle more power than traditional materials like silicon — to produce advanced chips. The company plans to have its first installation set up in New York within the next 18 months. "These fabs do not require billions in capital expenditure or large populations of highly trained workers," Putman told BI in a follow-up email. "The vision is that any region — whether in the Global South or the United States — should be able to produce what it needs locally."
Yahoo
6 hours ago
- Yahoo
Stem (STEM) Soars 8.8%: Is Further Upside Left in the Stock?
Stem, Inc. STEM shares ended the last trading session 8.8% higher at $6.71. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 33.7% loss over the past four weeks. STEM is benefiting from its focus on high-margin software and services, particularly PowerTrack and managed services, along with cost reductions and improved operational efficiency. This company is expected to post quarterly loss of $3.00 per share in its upcoming report, which represents a year-over-year change of +31.8%. Revenues are expected to be $33.1 million, down 2.7% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For Stem, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on STEM going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Stem is part of the Zacks Computers - IT Services industry. Cognizant CTSH, another stock in the same industry, closed the last trading session 0.8% higher at $77.59. CTSH has returned -4.3% in the past month. Cognizant's consensus EPS estimate for the upcoming report has changed +0.7% over the past month to $1.26. Compared to the company's year-ago EPS, this represents a change of +7.7%. Cognizant currently boasts a Zacks Rank of #2 (Buy). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Stem, Inc. (STEM) : Free Stock Analysis Report Cognizant Technology Solutions Corporation (CTSH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hill
6 hours ago
- The Hill
G7 agrees to exclude US from corporate minimum tax
The Group of Seven (G7) said Saturday that it will allow American companies to be excluded from a global minimum tax imposed by other countries, creating instead a 'side-by-side' agreement where regular American tax rules would apply. In 2021, nearly 140 countries agreed to tax multinational companies at a minimum rate of 15 percent, regardless of where they were headquartered, in a deal aimed at preventing conglomerates from seeking out tax havens. The Biden administration was then a proponent of the deal, as it was in line with its plans to raise the corporate tax rate. The Friday move by the G7 is nonbinding and still requires approval from the OECD, the intergovernmental organization that established the 2021 agreement. But the G7 members, which include the world's largest economies, dominate the OECD. The G7 statement is a major win for the Trump administration, which has pushed for the United States to be exempted from the tax agreement. The 'big, beautiful bill' now making its way through the Senate initially included a 'revenge tax' that would have imposed a levy of up to 20 percent on investments from countries with economic policies deemed to be unfair to American businesses, a broad definition that could have included the OECD deal. The language was pulled Thursday after Treasury Secretary Scott Bessent said progress with the G7 had been made, a move celebrated by congressional Republicans. 'We applaud President Trump and his team for protecting the interests of American workers and businesses after years of congressional Republicans sounding the alarm on the Biden Administration's unilateral global tax surrender under Pillar 2,' wrote Sen. Mike Crapo (R-Ind.) and Rep. Jason Smith (R-Mo.), the chairs of each chamber's tax policy committee.
